chr2-48688732-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000233.4(LHCGR):​c.1065T>C​(p.Asp355Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.585 in 1,613,476 control chromosomes in the GnomAD database, including 282,313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 22710 hom., cov: 31)
Exomes 𝑓: 0.59 ( 259603 hom. )

Consequence

LHCGR
NM_000233.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.456

Publications

21 publications found
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]
GTF2A1L (HGNC:30727): (general transcription factor IIA subunit 1 like) The assembly and stability of the RNA polymerase II transcription pre-initiation complex on a eukaryotic core promoter involve the effects of transcription factor IIA (TFIIA) on the interaction between TATA-binding protein (TBP) and DNA. This gene encodes a germ cell-specific counterpart of the large (alpha/beta) subunit of general transcription factor TFIIA that is able to stabilize the binding of TBP to DNA and may be uniquely important to testis biology. Alternative splicing for this locus has been observed and two variants, encoding distinct isoforms, have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (SALF), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-48688732-A-G is Benign according to our data. Variant chr2-48688732-A-G is described in ClinVar as Benign. ClinVar VariationId is 255607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.456 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.907 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LHCGRNM_000233.4 linkc.1065T>C p.Asp355Asp synonymous_variant Exon 11 of 11 ENST00000294954.12 NP_000224.2 P22888-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LHCGRENST00000294954.12 linkc.1065T>C p.Asp355Asp synonymous_variant Exon 11 of 11 1 NM_000233.4 ENSP00000294954.6 P22888-1
ENSG00000279956ENST00000602369.3 linkn.*220+5492T>C intron_variant Intron 9 of 12 5 ENSP00000473498.1 R4GN57

Frequencies

GnomAD3 genomes
AF:
0.527
AC:
80031
AN:
151860
Hom.:
22709
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.313
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.634
Gnomad ASJ
AF:
0.644
Gnomad EAS
AF:
0.929
Gnomad SAS
AF:
0.605
Gnomad FIN
AF:
0.579
Gnomad MID
AF:
0.657
Gnomad NFE
AF:
0.581
Gnomad OTH
AF:
0.569
GnomAD2 exomes
AF:
0.614
AC:
154217
AN:
251310
AF XY:
0.612
show subpopulations
Gnomad AFR exome
AF:
0.303
Gnomad AMR exome
AF:
0.708
Gnomad ASJ exome
AF:
0.669
Gnomad EAS exome
AF:
0.930
Gnomad FIN exome
AF:
0.574
Gnomad NFE exome
AF:
0.584
Gnomad OTH exome
AF:
0.616
GnomAD4 exome
AF:
0.591
AC:
863015
AN:
1461496
Hom.:
259603
Cov.:
45
AF XY:
0.591
AC XY:
429728
AN XY:
727068
show subpopulations
African (AFR)
AF:
0.306
AC:
10238
AN:
33476
American (AMR)
AF:
0.698
AC:
31226
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.664
AC:
17357
AN:
26134
East Asian (EAS)
AF:
0.936
AC:
37144
AN:
39700
South Asian (SAS)
AF:
0.600
AC:
51711
AN:
86252
European-Finnish (FIN)
AF:
0.573
AC:
30627
AN:
53418
Middle Eastern (MID)
AF:
0.695
AC:
4010
AN:
5766
European-Non Finnish (NFE)
AF:
0.580
AC:
644231
AN:
1111640
Other (OTH)
AF:
0.604
AC:
36471
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
19368
38736
58104
77472
96840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17834
35668
53502
71336
89170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.527
AC:
80067
AN:
151980
Hom.:
22710
Cov.:
31
AF XY:
0.534
AC XY:
39678
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.313
AC:
12970
AN:
41438
American (AMR)
AF:
0.634
AC:
9678
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.644
AC:
2235
AN:
3472
East Asian (EAS)
AF:
0.929
AC:
4797
AN:
5164
South Asian (SAS)
AF:
0.606
AC:
2921
AN:
4818
European-Finnish (FIN)
AF:
0.579
AC:
6118
AN:
10566
Middle Eastern (MID)
AF:
0.648
AC:
188
AN:
290
European-Non Finnish (NFE)
AF:
0.581
AC:
39513
AN:
67956
Other (OTH)
AF:
0.569
AC:
1198
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1791
3583
5374
7166
8957
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.572
Hom.:
49585
Bravo
AF:
0.526
Asia WGS
AF:
0.700
AC:
2437
AN:
3478
EpiCase
AF:
0.590
EpiControl
AF:
0.594

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 26, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hypergonadotropic hypogonadism Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leydig cell agenesis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Gonadotropin-independent familial sexual precocity Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.3
DANN
Benign
0.74
PhyloP100
0.46
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11125179; hg19: chr2-48915871; COSMIC: COSV108111124; API